Pharmacotechnical aspects of a stable probiotic formulation toward multidrug-resistance antibacterial activity: design and quality control

Table 2 Bacterial stability of all designed formulations, bacterial CFU in days 1, 7, and 14 at 8 °C

Formulation	CFU count- Day 1 (CFU/ml)	CFU count- Day 7 (CFU/ml)	CFU count- Day 14 (CFU/ml)
F1	0.1 × 10⁹	1 × 10⁵	0
F1-Solvent	0.11 × 10⁹	0.26 × 10⁶	0
F1-Control	0	0	0
F2	0.45 × 10⁸	0.4 × 10⁵	0
F2-Solvent	0.84 × 10⁸	0.57 × 10⁷	0
F2-Control	0	0	0
F3	0.31 × 10⁹	0.3 × 10⁵	0
F3-Solvent	0.59 × 10⁹	0.23 × 10⁶	0
F3-Control	0	0	0
F4	0.18 × 10⁹	0.49 × 10⁸	1.1 × 10⁷
F4-Solvent	0.15 × 10⁹	0.78 × 10⁸	0.41 × 10⁸
F4-Control	0	0	0
F5	0.1 × 10⁹	0.5 × 10⁵	0.03 × 10³
F5-Solvent	0.14 × 10⁹	0.75 × 10⁹	0.5 × 10⁴
F5-Control	0	0	0

ISSN: 2662-7671